Bonds will be firmer today after the Q3 results; poultry and Meals and Bakery margins were both above our expectations. So far,
Read MoreThe news that 2 Sisters has passed £70m of additional tax and wage costs to supermarkets will be supportive of the SSNs, but the
Read MoreBoparan continues to surprise us on the upside. Strong performance in the Poultry business more than made up for continued weakness in
Read MoreRangit and Baljinder’s private office has bought German turkey producer Heidemark through its European arm,
Read MorePoultry beat our expectations by £5m EBITDA, but it’s the topline that surprises us. Still driven by inflation recovery, it more than
Read MoreThe appointment of a new head for the Meals and Bakery business may be a sign of changes; we expect this division will eventually be
Read MoreThe upgrade to B+ will not make too much difference to the potential holder base, as the company rating was already B. We are sceptical that the current
Read MoreThe Q4 numbers exceeded our expectations, but we expect FYE 2026 to be tougher, as grocery customers seek to shore up their
Read MoreWe expect the Meals and Bakery business to eventually be sold by Boparan. The rescue of Roberts Bakery by the Boparan Private Office suggests a
Read MoreRevenue and EBITDA (including margins) were ahead of our estimates. Poultry benefited from destocking, which boosted prices. However,
Read MorePurchasing the other 50% of the Hook2Sisters will give the Boparan Family Office more opportunities to manage the margins at
Read MoreQuickly finding a replacement for the old CFO is a positive for Boparan/2 Sisters. With the refinance behind them, the new CFO has
Read MoreCongratulations to Ranjit Boparan for finishing the London Marathon and raising £140k for charity.
Read MoreTopline and Gross Profit/EBITDA were broadly in line with our estimates; operating cash flow was higher due to a better-than-expected payables performance in
Read MoreSourcing some of its chicken from Germany is more about ASDA’s lower prices campaign than it is about supply chain challenges. It sends a warning shot to
Read MoreCMA approval for the Boparan family to purchase ForFarmers may provide some scope to support Boparan, but with 75% of sales subject to ratchets
Read More